Argenx to present at upcoming investor conferences

November 10, 2021 breda, the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that members of management will participate in several upcoming conferences:

ARGX Ratings Summary

ARGX Quant Ranking